HighTower Advisors
MEDP icon

HighTower Advisors’s Medpace MEDP Stock Holding History

HighTower Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$204 – 3882
2024
Q2 		$204 Buy
+100
New +$39.6K ﹤0.01% 3617

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

HighTower Advisors's MEDP Position: Q1 2026 in Review

HighTower Advisors reduced its Medpace (MEDP) stake by 14% in Q1 2026, selling an estimated $395K and leaving 4,682 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

HighTower Advisors first reported a position in MEDP in Q3 2019 and has held it in 22 quarters since. The position peaked at $3.42M in Q2 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • HighTower Advisors held 4,682 shares of Medpace worth $2.25M as of Q1 2026.
  • HighTower Advisors sold 771 Medpace shares in Q1 2026, an estimated $395K.
  • Medpace made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #1647 holding.
  • HighTower Advisors first reported a position in Medpace in Q3 2019 and has held it in 22 quarters since.
  • HighTower Advisors's Medpace position peaked at $3.42M in Q2 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.